Coquitlam, Canada

Christopher James Barbosa

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christopher James Barbosa: Innovator in Lipid Nanoparticle Formulations

Introduction

Christopher James Barbosa is a notable inventor based in Coquitlam, Canada. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of lipid nanoparticles. With a total of two patents to his name, Barbosa's work focuses on improving drug delivery systems.

Latest Patents

Barbosa's latest patents include innovative formulations of lipid nanoparticles. These improved formulations are designed for the effective delivery of therapeutic agents. Additionally, he has developed a method for the preparation of liposome encapsulated vincristine for therapeutic use. This method enhances the efficiency of constituting liposome encapsulated vincristine for intravenous injection while reducing the risk of operational errors and contamination.

Career Highlights

Throughout his career, Barbosa has worked with prominent companies in the pharmaceutical industry. He has been associated with Acuitas Therapeutics, Inc. and Spectrum Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in drug delivery systems and formulation technologies.

Collaborations

Barbosa has collaborated with several professionals in his field, including Michael J. Hope and Barbara Mui. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical formulations.

Conclusion

Christopher James Barbosa is a distinguished inventor whose work in lipid nanoparticle formulations has the potential to advance therapeutic delivery methods. His contributions to the field are marked by his innovative patents and collaborations with industry professionals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…